AAAAAA

   
Results: 1-8 |
Results: 8
Immunoprotective therapy with targeted anticancer drugs
Authors: Rihova, B Strohalm, J Hoste, K Jelinkova, M Hovorka, O Kovar, M Plocova, D Sirova, M Stastny, M Schacht, E Ulbrich, K
Citation: B. Rihova et al., Immunoprotective therapy with targeted anticancer drugs, MACRO SYMP, 172, 2001, pp. 21-28
Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes
Authors: Rihova, B Etrych, T Pechar, M Jelinkova, M Stastny, M Hovorka, O Kovar, M Ulbrich, K
Citation: B. Rihova et al., Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes, J CONTR REL, 74(1-3), 2001, pp. 225-232
New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage:synthesis and preliminary in vitro and in vivo biological properties
Authors: Etrych, T Jelinkova, M Rihova, B Ulbrich, K
Citation: T. Etrych et al., New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage:synthesis and preliminary in vitro and in vivo biological properties, J CONTR REL, 73(1), 2001, pp. 89-102
Antiproliferative effect of a lectin- and anti-Thy-1.2 antibody-targeted HPMA copolymer-bound doxorubicin on primary and metastatic human colorectal carcinoma and on human colorectal carcinoma transfected with the mouse Thy-1.2 gene
Authors: Rihova, B Jelinkova, M Strohalm, J St'astny, M Hovorka, O Plocova, D Kovar, M Draberova, L Ulbrich, K
Citation: B. Rihova et al., Antiproliferative effect of a lectin- and anti-Thy-1.2 antibody-targeted HPMA copolymer-bound doxorubicin on primary and metastatic human colorectal carcinoma and on human colorectal carcinoma transfected with the mouse Thy-1.2 gene, BIOCONJ CHE, 11(5), 2000, pp. 664-673
Hydrophilic polymers for drug delivery
Authors: Ulbrich, K Subr, V Pechar, M Strohalm, J Jelinkova, M Rihova, B
Citation: K. Ulbrich et al., Hydrophilic polymers for drug delivery, MACRO SYMP, 152, 2000, pp. 151-162
Polymeric drugs based on conjugates of synthetic and natural macromolecules I. Synthesis and physico-chemical characterisation
Authors: Ulbrich, K Subr, V Strohalm, J Plocova, D Jelinkova, M Rihova, B
Citation: K. Ulbrich et al., Polymeric drugs based on conjugates of synthetic and natural macromolecules I. Synthesis and physico-chemical characterisation, J CONTR REL, 64(1-3), 2000, pp. 63-79
Polymeric drugs based on conjugates of synthetic and natural macromolecules. II. Anti-cancer activity of antibody or (Fab ')(2)-targeted conjugates and combined therapy with immunomodulators
Authors: Rihova, B Jelinkova, M Strohalm, J Subr, V Plocova, D Hovorka, O Novak, M Plundrova, D Germano, Y Ulbrich, K
Citation: B. Rihova et al., Polymeric drugs based on conjugates of synthetic and natural macromolecules. II. Anti-cancer activity of antibody or (Fab ')(2)-targeted conjugates and combined therapy with immunomodulators, J CONTR REL, 64(1-3), 2000, pp. 241-261
Brain lesion-induced alteration of selected phenotypic properties of spleen macrophages and their partial restoration in the course of foreign body reaction against intraperitoneally implanted polymers
Authors: Smetana, K Petrovicky, P Zach, P Nemcova, V Jelinkova, M Vacik, J Gabius, HJ
Citation: K. Smetana et al., Brain lesion-induced alteration of selected phenotypic properties of spleen macrophages and their partial restoration in the course of foreign body reaction against intraperitoneally implanted polymers, J MAT S-M M, 10(7), 1999, pp. 425-429
Risultati: 1-8 |